Detailed view for TGME49_249260

Basic information

TDR Targets ID: 257791
Toxoplasma gondii, cell-cycle-associated protein kinase CDK, putative
Source Database / ID:  ToxoDB 

pI: 9.5745 | Length (AA): 1908 | MW (Da): 212038 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG5

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0004672   protein kinase activity  
GO:0005524   ATP binding  
GO:0004713   protein tyrosine kinase activity  
GO:0004674   protein serine/threonine kinase activity  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 12 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
396 896 1koa () 5939 6311 21.00 0 1 -0.03 1.11
576 699 2gfs (A) 122 242 38.00 0 1 0.59 -1.09
341 431 3q5z (A) 177 265 25.00 0 0.09 0.219894 -0.33
372 863 2xrw (A) 3 331 31.00 0.0000000072 1 -0.131138 1.65
396 859 3ddq (C) 0 294 46.00 0 1 -0.149813 1.49
455 1021 4kik (A) 10 653 14.00 0.00028 0.95 0.25857 0.85
460 626 2hw6 (A) 52 194 23.00 0.0000032 0.1 0.00592621 0.73
479 878 1cm8 (A) 47 347 27.00 0 1 0.0670436 1.14
581 630 3aln (A) 203 284 42.00 0.0097 0.89 0.402205 0.69
597 630 2qlu (A) 313 346 53.00 0.028 0.26 0.42782 1.22
761 855 5cem (A) 252 340 29.00 0.0037 0.25 0.31719 -0.31
1360 1559 5cwg (A) 5 194 18.00 0 0.13 0.261022 -0.91

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile ME49 Oocyst, ME49 Bradyzoite. Fritz HM Sibley/Greg
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile VEG Tachyzoite, ME49 Tachyzoite. Gregory
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile ME49 merozoite. Hehl AB
Show/Hide expression data references
  • Fritz HM Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts.
  • Sibley/Greg ToxoDB
  • Hehl AB Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes.
  • Gregory ToxoDB

Orthologs

Ortholog group members (OG5_135486)

Species Accession Gene Product
Babesia bovis BBOV_I001950   protein kinase domain containing protein
Cryptosporidium hominis Chro.60177   cdc2-related protein kinase
Cryptosporidium parvum cgd6_1420   cdc2-related protein kinase, putative
Leishmania braziliensis LbrM.27.2100   protein kinase-like protein
Leishmania donovani LdBPK_271860.1   cdc2-related kinase 9
Leishmania infantum LinJ.27.1860   protein kinase-like protein
Leishmania major LmjF.27.1940   protein kinase-like protein
Leishmania mexicana LmxM.27.1940   protein kinase-like protein
Neospora caninum NCLIV_065460   CMGC kinase, putative
Plasmodium berghei PBANKA_0717300   cdc2-related protein kinase 3
Plasmodium falciparum PF3D7_0415300   cdc2-related protein kinase 3
Plasmodium knowlesi PKNH_0506900   protein kinase, putative
Plasmodium vivax PVX_089720   protein kinase domain containing protein
Plasmodium yoelii PY04026   cdc-2 related kinase 3
Trypanosoma brucei gambiense Tbg.972.2.2560   protein kinase, putative
Trypanosoma brucei Tb927.2.4510   cdc2-related kinase 9
Trypanosoma congolense TcIL3000_2_850   cdc2-related kinase 9
Trypanosoma cruzi TcCLB.507209.40   cdc2-related kinase 9
Trypanosoma cruzi TcCLB.509099.150   cdc2-related kinase 9
Toxoplasma gondii TGME49_249260   cell-cycle-associated protein kinase CDK, putative
Theileria parva TP03_0140   cell division cycle 2 protein kinase, putative

Essentiality

TGME49_249260 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.2.4510 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.2.4510 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
PBANKA_0717300 Plasmodium berghei Essential plasmo
TGME49_249260 this record Toxoplasma gondii Essentiality uncertain sidik
Show/Hide essentiality data references
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Druggability index (range: 0 to 1): 0.5

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.0033 1 1
0.0016 0.5 0.5
0.0012 0.5 0.5
0.0007 0.5 0.5
0.0037 1 0.5
0.0039 0.5 0.5
0.0032 0.5 0.5
0.0012 0.5 0.5
0.0003 0.5 0.5
0.0012 0.5 0.5
0.0056 1 0.5
0.0088 0.4477 1
0.0081 1 0.5
0.0032 0.5 0.5
0.0093 0.8828 0
0.0022 0.5 0.5
0.0059 1 1
0.0063 0.7244 0.7244
0.0064 0.3377 0
0.0029 0.5 0.5
0.0011 1 0.5
0.0092 1 0.5
0.0008 0.5 0.5
0.0039 0.9485 0.5
0.0098 0.3242 0.2614
0.0007 0.5 0.5
0.0023 0.5 0.5
0.0059 1 1
0.0062 0.6935 0
0.0066 0.3101 0
0.0067 0.5 0.5
0.0016 0.5 0.5
0.0027 1 0.5
0.0036 0.5 0.5
0.0039 0.5 0.5
0.0061 0.6883 0.6656
0.0026 0.5 0.5
0.0018 0.5 0.5
0.0042 0.5 0.5
0.0059 1 1
0.0069 0.3067 1
0.0091 1 0.5
0.0081 0.5 0.5
0.0004 0.5 0.5
0.0063 1 1
0.0033 0.5 0.5
0.0007 0.5 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier TGME49_249260 (Toxoplasma gondii), cell-cycle-associated protein kinase CDK, putative
Title for this comment
Comment